Overcoming Genetic Drivers In Alopecia Areata: Hair Regrowth In A Patient With AIRE Gene Mutation (Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy, APECED Syndrome) Treated With Ruxolitinib

    January 2026 in “ Clinical and Experimental Dermatology ”
    James Irvine, Susan Holmes
    Studysummary In this case report, complete hair regrowth was observed in a patient with autoimmune-related alopecia areata after treatment with a Janus kinase inhibitor, suggesting its potential effectiveness for both genetic and sporadic forms of the condition.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1 New England Journal of Medicine · 2024
    2. Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients With APS-1 Journal of clinical immunology · 2023